Within a few years of using prostate-specific antigen (PSA) tests, we saw an amazing shift: By the mid-1990s, most men newly diagnosed with prostate cancer were curable. Since then, studies have shown that while PSA screening reduces a man’s likelihood of dying from prostate cancer, it does not reduce overall mortality. The problem has been with how we use PSA tests.
Prostate cancer can be hard to detect. Deciding what to do about it if we find or suspect it can be even tougher, for patients and their doctors.
Common myths about prostate cancer, including misconceptions about prostate-specific-antigen (PSA) testing and prostate surgery.
It’s easy to see why men are confused with so much conflicting information about the right way to screen, diagnose and treat prostate cancer.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
When men turn 40, they may think about how to keep their hair or lose their belly, but they may not think about seeing a urologist.
When should you get tested for prostate cancer? Our experts explain.